InsidersTradesSigma
Browse the complete record of transactions filed by Vachon Mark, Director. Director active across 1 companies, notably bluebird bio, Inc.. Aggregated, 5 reports have been logged. The latest transaction was filed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Mark Vachon is a Board Member at bluebird bio, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector allows him to bring valuable insights to the management team. Mark is committed to supporting bluebird bio's mission to develop innovative therapies for genetic diseases.